Part of the ICU Emergencies Hub — browse every related guide in one place.
ICU drips, titration protocols, sedation-analgesia-delirium management, neuromuscular blockers, insulin infusions, and the bedside knowledge every ICU nurse must have.
Goal: minimize sedation depth, reduce delirium, decrease ventilator days, improve long-term outcomes.
| CPOT Category | 0 (No Pain) | 1 (Moderate Pain) | 2 (Severe Pain) |
|---|---|---|---|
| Facial expression | Relaxed | Tense/grimace | Grimacing/distorted |
| Body movements | Absence of movements/normal | Protection (slow, cautious) | Restlessness/agitation |
| Muscle tension (arm flex/extend) | Relaxed | Tense/rigid | Very tense/rigid |
| Ventilator compliance (vented) | Tolerating vent well | Coughing/alarming | Fighting ventilator |
| Vocalization (non-vented) | No sound | Moaning, crying | Screaming |
CPOT score ≥3 = pain present → treat. Maximum score = 8. Use NRS 0–10 for patients who can self-report.
| Drug | Route | Dose Range | Key Nursing Points |
|---|---|---|---|
| Fentanyl | IV infusion or bolus | Infusion: 25–200 mcg/hr; Bolus: 25–100 mcg IV q1–2h PRN | Preferred ICU opioid; less histamine release than morphine; renally safe; lipophilic — accumulates with prolonged infusion; reduce dose with liver disease |
| Morphine | IV bolus or infusion | 2–4 mg IV q2–4h PRN or infusion | Active metabolite (morphine-6-glucuronide) accumulates in renal failure → prolonged sedation; histamine release → bronchospasm, hypotension; avoid in asthma, hemodynamically unstable |
| Hydromorphone (Dilaudid) | IV, PO | 0.2–1 mg IV q3–4h PRN | 5–10× more potent than morphine; similar to fentanyl for ICU use; renal dose adjustment needed |
| Ketamine | IV bolus or infusion | Analgesic dose: 0.1–0.3 mg/kg/hr infusion | Dissociative analgesic; bronchodilator (useful in asthma); maintains airway reflexes; emergence reactions (dysphoria, hallucinations) — give with low-dose benzo; INCREASES secretions (have suction ready); preserves hemodynamics |
| Acetaminophen | IV, PO, PR | 650–1,000 mg q6h (max 4g/day; 2g/day in liver disease) | Opioid-sparing effect; non-opioid baseline analgesia; safe with renal failure |
| Score | Description |
|---|---|
| +4 | Combative — violent, danger to staff |
| +3 | Very agitated — pulls tubes/lines, aggressive |
| +2 | Agitated — frequent purposeless movement, fights ventilator |
| +1 | Restless — anxious, movements not aggressive |
| 0 | Alert and calm |
| -1 | Drowsy — not fully alert, sustained awakening >10 sec to voice |
| -2 | Light sedation — briefly awakens <10 sec to voice |
| -3 | Moderate sedation — movement to voice but no eye contact |
| -4 | Deep sedation — no response to voice, moves to physical stimulation |
| -5 | Unarousable — no response to any stimulation |
| Drug | Dose | Key Points |
|---|---|---|
| Propofol (Diprivan) | 5–50 mcg/kg/min infusion | Rapid onset/offset (excellent for SATs); PROPOFOL INFUSION SYNDROME (PIS) with doses >83 mcg/kg/min >48 hr → metabolic acidosis, rhabdo, cardiac failure; monitor triglycerides (propofol in lipid emulsion = 1.1 kcal/mL); hypotension and bradycardia; do NOT use in egg/soy allergy |
| Midazolam (Versed) | 0.02–0.1 mg/kg/hr infusion | Benzo — accumulates with prolonged infusion (active metabolite); associated with more delirium than propofol or dexmedetomidine; use short-term or for acute agitation; respiratory depression |
| Dexmedetomidine (Precedex) | 0.2–1.5 mcg/kg/hr infusion (loading dose optional) | Alpha-2 agonist; sedation WITHOUT respiratory depression (patient breathes); arousable/cooperative (allows assessment); reduces delirium; bradycardia and hypotension; caution in patients needing deep sedation (not adequate for NMBs); rebound HTN if stopped abruptly after prolonged use |
| Lorazepam (Ativan) | 0.01–0.1 mg/kg/hr infusion or PRN boluses | Only preferred benzo for: alcohol/benzo withdrawal; status epilepticus; use shorter durations; propylene glycol accumulation with high doses → anion gap acidosis |
| Ketamine | 0.5–2 mg/kg/hr infusion | Anesthetic/dissociative; used for procedural sedation, refractory agitation; increases BP, HR (useful in hemodynamically unstable); increases secretions; emergence reactions |
| Drug | Type | Dose | Duration | Key Facts |
|---|---|---|---|---|
| Cisatracurium (Nimbex) | Non-depolarizing (Hofmann elimination) | 0.1–0.2 mg/kg IV bolus; 1–3 mcg/kg/min infusion | 45–75 min bolus | Preferred ICU NMBA — eliminated by plasma esterases (not organ-dependent); safe in renal/liver failure; no histamine release; use for ARDS with P/F <150 |
| Succinylcholine (Anectine) | Depolarizing | 1–1.5 mg/kg IV bolus | 8–12 min | Rapid sequence intubation — fastest onset (60–90 sec); ultrashort duration; AVOID in: hyperkalemia, burns >24 hr, crush injury, spinal cord injury (massive K+ release), myopathy; phase II block if repeated doses |
| Rocuronium (Zemuron) | Non-depolarizing | 0.6–1.2 mg/kg IV | 30–60 min | RSI alternative to succinylcholine when it's contraindicated; reversed by sugammadex (Bridion) — binds and removes rocuronium; higher dose (1.2 mg/kg) → 90 sec onset (comparable to succinylcholine for RSI) |
| Vecuronium | Non-depolarizing | 0.1 mg/kg IV; infusion 1–2 mcg/kg/min | 25–40 min | Renally cleared — accumulates in renal failure; rarely used in modern ICU (cisatracurium preferred) |
Used when NMBAs are infused continuously. Peripheral nerve stimulator delivers 4 electrical impulses to ulnar nerve; observe thumb twitches.
SAT (Spontaneous Awakening Trial):
SBT (Spontaneous Breathing Trial):
Get The ICU Notebook Newsletter
Clinical tools and career insights for ICU nurses. One email per week, no fluff.
Yes, send it freeNo spam. Unsubscribe any time.